Suven Life Sciences Rights Issue 2022 will open on October 31, 2022, and close on November 10, 2022. The business decided on October 18, 2022 as the record date for the rights issue. The firm will offer 72,691,239 shares through this rights issue and will raise 399.80 crores through this issue, and the company Suven Life Sciences Rights Issue Price of this issue has been announced at 55 per share as per the face value of 1.
Suven Life Sciences Ltd is a clinical-stage biopharmaceutical business dedicated to the acquisition, development, and commercialization of new neurodegenerative treatments. Custom Synthesis Process R&D Scale Up and Contract Manufacturing of Intermediates, APIs, and Formulations are among the company’s offerings. Suven Life Sciences has advanced from contract research to collaborative study design, moving away from project-based transactions and towards relationship-based business.
Object of the Issue :
- Meeting costs related to pharmaceutical research & development and clinical trial for molecules in the research pipelines.
- Repayment of an inter-corporate deposit availed by the Company.
- General corporate purposes.
Suven Life Sciences Rights issue 2022 Date & Price Details :
| Issue Open : | 31 October 2022 |
| Issue Close : | 10 November 2022 |
| Record Date : | 18 October 2022 |
| Issue Size : | ₹399.80 Cr |
| Face Value : | ₹1 Rs. Equity Share |
| Price Band : | ₹55 Per Share |
| Listing On : | BSE, NSE |
| Issue Shares Offer : | 72,691,239 |
| Ratio : | 1:2 |
Suven Life Sciences Rights issue 2022 Date :
| Bid Open Date : | 31 October 2022 |
| Bid Close Date : | 10 November 2022 |
| Record Date : | 18 October 2022 |
| Allotment Date : | 18 November 2022 |
| Share Credit Date : | 21 November 2022 |
| Listing Date : | 24 November 2022 |
Suven Life Sciences Financial Report (Cr):
| Year | Revenue | Expense | P&L |
|---|---|---|---|
| 2022 | ₹12.00 | ₹134.00 | ₹-122.00 |
| 2021 | ₹13.00 | ₹93.00 | ₹-72.00 |
| 2020 | ₹13.00 | ₹12800 | ₹-94.00 |
Suven Life Sciences Rights Issue Lead Manager :
Ernst & Young Merchant Banking Services LLP
The Ruby, 14th Floor, 29 Senapati Bapat Marg,
Dadar (W) – 400028, Mumbai
Maharashtra, India
Tel No.: +91 22 6192 0000
Email: [email protected]
Investor grievance e-mail: [email protected]
Website: https://www.ey.com/in/mb
Company Address :
Suven Life Sciences Limited
8-2-334, SDE Serene Chambers,
6th Floor Road No.5, Avenue 7,
Banjara Hills, Hyderabad – 500 034
Tel: +91 40 2354 1142
Email: [email protected]
Website: http://www.suven.com
Suven Life Sciences Rights Issue Registrar :
KFin Technologies Limited
Selenium, Tower B, Plot No- 31 and 32,
Financial District, Nanakramguda,
Serilingampally, Hyderabad, Rangareddi 500 032,
Telangana, India
Tel: +91 40 6716 2222
Email: [email protected]
Investor Grievance e-mail: [email protected]
Website: https://www.kfintech.com
How to apply Suven Life Sciences Rights Issue :
- Visit the registrar’s website
- Go to the ‘Rights Issue’ section
- Select Suven Life Sciences Rights Issue from the dropdown.
- Enter Demat Account Number.
- Fill the online application form.
- Validate and submit the application.
Suven Life Sciences Rights Issue 2022 FAQs :
Q1. What is Suven Life Sciences Rights Issue Open Date?
Ans. Suven Life Sciences Rights Issue 2022 Open date is 31 October 2022.
Q2. What is Suven Life Sciences Rights Issue Close Date?
Ans. Suven Life Sciences Rights Issue 2022 Close date is 10 Nvember 2022.
Q3. When is Suven Life Sciences Rights Issue 2022 Record Date?
Ans. Suven Life Sciences Rights Issue 2022 record date is 18 October 2022.
Q4. What is Suven Life Sciences Rights Issue Price?
Ans. The company has fixed the price at ₹55 per share.
Q5. What is Suven Life Sciences Rights Issue 2022 Size?
Ans. The company Suven Life Sciences Rights Issue Size is ₹399.80 Cr.
Q6. What is Suven Life Sciences Rights Issue Ratio?
Ans. The company has fixed the ratio Of 1:2.
Q7. How to apply for Suven Life Sciences Rights Issue 2022?
Ans. You can apply for the Suven Life Sciences Rights Issue in two ways:
1. Net Banking (ASBA)
2. Registrar’s Website
